Role of the β1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo

61Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Anesthetic and ischemic preconditioning share similar signal transduction pathways. The authors tested the hypothesis that the β1-adrenergic signal transduction pathway mediates anesthetic and ischemic preconditioning in vivo. METHODS: Pentobarbital-anesthetized (30 mg/kg) rabbits (n = 96) were instrumented for measurement of systemic hemodynamics and subjected to 30 min of coronary artery occlusion and 3 h of reperfusion. Sixty minutes before occlusion, vehicle (control), 1.0 minimum alveolar concentration desflurane, or sevoflurane, and esmolol (30.0 mg·kg·h) were administered for 30 min, respectively. Administration of a single 5-min cycle of ischemic preconditioning was instituted 35 min before coronary artery occlusion. In separate groups, the selective blocker esmolol or the protein kinase A inhibitor H-89 (250 μg/kg) was given alone and in combination with desflurane, sevoflurane, and ischemic preconditioning. RESULTS: Baseline hemodynamics and area at risk were not significantly different between groups. Myocardial infarct size (triphenyltetrazolium staining) as a percentage of area at risk was 61 ± 4% in control. Desflurane, sevoflurane, and ischemic preconditioning reduced infarct size to 34 ± 2, 36 ± 5, and 23 ± 3%, respectively. Esmolol did not alter myocardial infarct size (65 ± 5%) but abolished the protective effects of desflurane and sevoflurane (57 ± 4 and 52 ± 4%, respectively) and attenuated ischemic preconditioning (40 ± 4%). H-89 did not alter infarct size (60 ± 4%) but abolished preconditioning by desflurane (57 ± 5%) and sevoflurane (61 ± 1%). Ischemic preconditioning (24 ± 7%) was not affected by H-89. CONCLUSIONS: The results demonstrate that anesthetic preconditioning is mediated by the β1-adrenergic pathway, whereas this pathway is not essential for ischemic preconditioning. These results indicate important differences in the mechanisms of anesthetic and ischemic preconditioning. Copyright © 2006, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.

Cite

CITATION STYLE

APA

Lange, M., Smul, T. M., Blomeyer, C. A., Redel, A., Klotz, K. N., Roewer, N., & Kehl, F. (2006). Role of the β1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology, 105(3), 503–510. https://doi.org/10.1097/00000542-200609000-00014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free